During the past decade, Cardiovascular Consultants, Ltd. conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 8 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Consultants, Ltd." #1 sponsor was "Boston Scientific Corporation" with 4 trials, followed by "Abbott Medical Devices" with 3 trials sponsored, "Gilead Sciences" with 3 trials sponsored, "Impulse Dynamics" with 2 trials sponsored and "University of Washington" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Consultants, Ltd." #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 5 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator, "Milton S. Hershey Medical Center" with 1 trials as a collaborator and "Northwestern University" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Consultants, Ltd." are "Heart Failure" (7 trials), "Atherosclerosis" (3 trials), "Cardiovascular Diseases" (3 trials), "Coronary Artery Disease" (3 trials) and "Coronary Disease" (3 trials). Many other conditions were trialed in "Cardiovascular Consultants, Ltd." in a lesser frequency.

Most popular intervention types in "Cardiovascular Consultants, Ltd." are "Drug" (10 trials), "Device" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Darusentan" (2 trials), "Guanfacine" (2 trials), "Placebo" (2 trials), "Simvastatin" (2 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Consultants, Ltd." are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Cardiovascular Consultants, Ltd.". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Cardiovascular Consultants, Ltd., undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Consultants, Ltd., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".